Compugen reported $2.34M in Trade Debtors for its fiscal quarter ending in March of 2026.





Trade Debtors Change Date
aTyr Pharma USD 906K 295.84M Mar/2026
Brainstorm Cell Therapeutics USD 86K 6K Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.34M 44K Mar/2026
Immunic USD 333K 156K Dec/2025
RedHill Biopharma USD 280K 5.07M Dec/2025
TherapeuticsMD USD 2.91M 310K Jun/2024